Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial

BACKGROUND: von Hippel-Lindau disease (VHL) is a multisystem cancer syndrome caused by mutations in the VHL gene. Retinal hemangioblastoma is one of the most common tumours, and when it appears near the optic nerve, its treatment is challenging and risky. To date, no treatment has proven effective i...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Rodríguez, Beatriz, Villar Gómez de las Heras, Karina, Aguirre, Daniel T, Rodríguez-Padial, Luis, Albiñana, Virginia, Recio-Poveda, Lucía, Cuesta, Angel M, Botella, Luisa Mª, Jiménez-Escribano, Rosa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557078/
https://www.ncbi.nlm.nih.gov/pubmed/31245608
http://dx.doi.org/10.1136/bmjophth-2018-000203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557078/
https://www.ncbi.nlm.nih.gov/pubmed/31245608
http://dx.doi.org/10.1136/bmjophth-2018-000203

Ejemplares similares